570 related articles for article (PubMed ID: 36499613)
1. Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets.
Hamzé R; Delangre E; Tolu S; Moreau M; Janel N; Bailbé D; Movassat J
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499613
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
[TBL] [Abstract][Full Text] [Related]
3. Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease.
Rad SK; Arya A; Karimian H; Madhavan P; Rizwan F; Koshy S; Prabhu G
Drug Des Devel Ther; 2018; 12():3999-4021. PubMed ID: 30538427
[TBL] [Abstract][Full Text] [Related]
4. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
[TBL] [Abstract][Full Text] [Related]
5. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
[TBL] [Abstract][Full Text] [Related]
6. The rise and fall of insulin signaling in Alzheimer's disease.
Chami B; Steel AJ; De La Monte SM; Sutherland GT
Metab Brain Dis; 2016 Jun; 31(3):497-515. PubMed ID: 26883429
[TBL] [Abstract][Full Text] [Related]
7. Type 2 Diabetes Mellitus and Alzheimer's Disease: A Review of the Potential Links.
Pakdin M; Toutounchian S; Namazi S; Arabpour Z; Pouladi A; Afsahi S; Poudineh M; Nasab MMM; Yaghoobpoor S; Deravi N
Curr Diabetes Rev; 2022; 18(8):e051121197760. PubMed ID: 34749616
[TBL] [Abstract][Full Text] [Related]
8. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
[TBL] [Abstract][Full Text] [Related]
9. Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer's Disease.
Rasool M; Malik A; Waquar S; Zaheer A; Asif M; Iqbal Z; Gauthaman K; Kamal MA; Pushparaj PN
CNS Neurol Disord Drug Targets; 2021; 20(7):602-612. PubMed ID: 33583389
[TBL] [Abstract][Full Text] [Related]
10. Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
Ali SK; Ali RH
PLoS One; 2022; 17(7):e0271138. PubMed ID: 35802659
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
Götz J; Schild A; Hoerndli F; Pennanen L
Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
[TBL] [Abstract][Full Text] [Related]
12. [Alzheimer's disease and diabetes - the common pathogenesis].
Halmos T; Suba I
Neuropsychopharmacol Hung; 2016 Mar; 18(1):5-19. PubMed ID: 27038867
[TBL] [Abstract][Full Text] [Related]
13. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
14. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
Kimura N
Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
[TBL] [Abstract][Full Text] [Related]
15. Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators.
Jayaraj RL; Azimullah S; Beiram R
Saudi J Biol Sci; 2020 Feb; 27(2):736-750. PubMed ID: 32210695
[TBL] [Abstract][Full Text] [Related]
16. Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function -- role of glucose metabolism and insulin signalling.
Rhein V; Eckert A
Arch Physiol Biochem; 2007 Jun; 113(3):131-41. PubMed ID: 17922309
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
[TBL] [Abstract][Full Text] [Related]
18. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
[TBL] [Abstract][Full Text] [Related]
19. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
Steen E; Terry BM; Rivera EJ; Cannon JL; Neely TR; Tavares R; Xu XJ; Wands JR; de la Monte SM
J Alzheimers Dis; 2005 Feb; 7(1):63-80. PubMed ID: 15750215
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes.
Michailidis M; Moraitou D; Tata DA; Kalinderi K; Papamitsou T; Papaliagkas V
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
